Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study

Sanne Maria Henriette Zweijpfenning; Raphael Chiron; Sharon Essink; Jodie Schildkraut; Onno W Akkerman; Stefano Aliberti; Josje Altenburg; Bert Arets; Eva van Braeckel; Bénédicte Delaere; Sophie Gohy; Eric Haarman; Natalie Lorent; Genevieve McKew; Lucy Morgan; Dirk Wagner; Jakko van Ingen; Wouter Hoefsloot

doi:10.1016/j.chest.2022.01.015

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study

Chest. 2022 Jul;162(1):76-81. doi: 10.1016/j.chest.2022.01.015. Epub 2022 Jan 19.

Authors

Sanne Maria Henriette Zweijpfenning¹, Raphael Chiron², Sharon Essink³, Jodie Schildkraut⁴, Onno W Akkerman⁵, Stefano Aliberti⁶, Josje Altenburg⁷, Bert Arets⁸, Eva van Braeckel⁹, Bénédicte Delaere¹⁰, Sophie Gohy¹¹, Eric Haarman⁷, Natalie Lorent¹², Genevieve McKew¹³, Lucy Morgan¹⁴, Dirk Wagner¹⁵, Jakko van Ingen⁴, Wouter Hoefsloot³

Affiliations

¹ Department of Pulmonary Diseases, Radboud University Medical Centre, Radboud University Medical Centre Dekkerswald, Nijmegen, The Netherlands. Electronic address: sanne.zweijpfenning@radboudumc.nl.
² University Medical Centre Montpellier, Montpellier, France.
³ Department of Pulmonary Diseases, Radboud University Medical Centre, Radboud University Medical Centre Dekkerswald, Nijmegen, The Netherlands.
⁴ Department of Medical Microbiology, Radboudumc Centre for Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ Department of Pulmonary Diseases, University Medical Centre Groningen, Groningen, The Netherlands; TB Center Beatrixoord, University Medical Centre Groningen, Groningen, The Netherlands.
⁶ Department of Biomedical Sciences, Humanitas University, Milan, Italy; Respiratory Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
⁷ Department of Pulmonary Diseases, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
⁸ Emma Children's Hospital, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
⁹ Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
¹⁰ Department of Infectious Diseases, University Hospital UCL Namur, Yvoir, Belgium.
¹¹ Department of Pulmonary Diseases and CF Reference Center, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
¹² Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
¹³ Department of Microbiology and Infectious Diseases, Concord Repatriation and General Hospital, NSW Health Pathology, Sydney, Australia; Department of Respiratory Medicine, Concord Clinical School, University of Sydney, Sydney, Australia.
¹⁴ Department of Microbiology and Infectious Diseases, Concord Repatriation and General Hospital, NSW Health Pathology, Sydney, Australia.
¹⁵ Department of Internal Medicine II, Division of Infectious Diseases, Freiburg University Medical Centre, Freiburg, Germany.

No abstract available

Publication types

Letter

MeSH terms

Amikacin
Anti-Bacterial Agents / therapeutic use
Humans
Liposomes
Lung Diseases* / drug therapy
Lung Diseases* / microbiology
Microbial Sensitivity Tests
Mycobacterium Infections, Nontuberculous* / drug therapy
Mycobacterium Infections, Nontuberculous* / microbiology
Mycobacterium abscessus*
Mycobacterium avium Complex
Nontuberculous Mycobacteria

Substances

Anti-Bacterial Agents
Liposomes
Amikacin